Medicare Enrolled

Dr. David Celko, M.D.

Pulmonary Disease · Mc Murray, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
455 VALLEYBROOK RD, Mc Murray, PA 15317
7249415588
In practice since 2006 (19 years)
NPI: 1164539920 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Celko from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Celko? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Celko

Dr. David Celko is a pulmonary disease specialist in Mc Murray, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Celko performed 35 Medicare services across 35 unique beneficiaries.

Between the years covered by Open Payments, Dr. Celko received a total of $14,351 from 60 pharmaceutical and/or device companies across 701 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Celko is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 35 Medicare services $14,351 industry payments

Medicare Practice Summary

Medicare Utilization ↗
35
Medicare services
Bottom 2% in PA for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
35
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
12 $42 $80
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
12 $93 $200
Hemoglobin measurement
A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen.
11 $5 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,351
Total received (2018-2024)
Avg $2,050/year across 7 years
Top 12% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
701
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,351 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14
2023
$813
2022
$698
2021
$2,538
2020
$3,916
2019
$3,645
2018
$2,727

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,978
AstraZeneca Pharmaceuticals LP
$1,573
Amgen Inc.
$1,396
Lilly USA, LLC
$658
Boehringer Ingelheim Pharmaceuticals, Inc.
$616
PFIZER INC.
$542
AbbVie Inc.
$484
Teva Pharmaceuticals USA, Inc.
$458
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$404
Novo Nordisk Inc
$335
GENZYME CORPORATION
$314
JAZZ PHARMACEUTICALS INC.
$313
Jazz Pharmaceuticals Inc.
$311
Janssen Pharmaceuticals, Inc
$306
Amarin Pharma Inc.
$278
Takeda Pharmaceuticals U.S.A., Inc.
$254
DERMIRA, INC.
$243
AbbVie, Inc.
$226
Abbott Laboratories
$225
Allergan, Inc.
$198
Allergan Inc.
$190
E.R. Squibb & Sons, L.L.C.
$167
Gilead Sciences, Inc.
$152
Advanced Respiratory, Inc
$148
Eisai Inc.
$141
SANOFI-AVENTIS U.S. LLC
$130
Vertical Pharmaceuticals, LLC
$121
Merck Sharp & Dohme Corporation
$118
Esperion Therapeutics, Inc.
$92
ABBVIE INC.
$88
Astellas Pharma US Inc
$70
Circassia Pharmaceuticals Inc
$66
Kowa Pharmaceuticals America, Inc.
$58
Sunovion Pharmaceuticals Inc.
$56
Currax Pharmaceuticals LLC
$55
ARBOR PHARMACEUTICALS, INC.
$48
HOSPIRA, INC.
$39
Shire North American Group Inc
$35
Biohaven Pharmaceuticals, Inc.
$35
RedHill Biopharma Inc.
$35
Concordia Pharmaceuticals Inc.
$32
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$32
Genentech USA, Inc.
$30
Novartis Pharmaceuticals Corporation
$29
Radius Health, Inc.
$29
Ethicon US, LLC
$27
Arbor Pharmaceuticals, Inc.
$27
Mallinckrodt Hospital Products Inc.
$20
VIVUS, Inc.
$20
Endo Pharmaceuticals Inc.
$18
Regeneron Healthcare Solutions, Inc.
$18
IRONWOOD PHARMACEUTICALS, INC
$17
Horizon Therapeutics plc
$14
Aytu BioScience, Inc
$14
Nabriva Therapeutics, plc
$13
Electromed, Inc.
$13
Orexigen Therapeutics, Inc.
$12
Mission Pharmacal Company
$12
Nalpropion Pharmaceuticals, Inc.
$11
Lupin Inc.
$11
Top 3 companies account for 41.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · ANORO · ANORO ELLIPTA · ANTARA · AREXVY · AUBAGIO · Aemcolo · Aimovig · AirDuo Digihaler · Androgel · BASAGLAR · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · Binosto · CHANTIX · CINQAIR · CONTRAVE · CREON · CYCLOSET · Corlanor · Creon · DONNATAL · DUPIXENT · Dayvigo · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Epclusa · FARXIGA · FASENRA · FreeStyle Libre blood glucose Flash Monitoring System · GLASSIA · Horizant · Infinity DBS Pulse Generators · JANUVIA · JARDIANCE · LINX Reflux Management System · LINZESS · LONHALA MAGNAIR · LORZONE · LYRICA · Life 2000 Ventilation System · LifeVest · Linzess · Livalo · METHYLPHENIDATE 72 · MOTEGRITY · MOUNJARO · MYDAYIS · MYRBETRIQ · Motegrity · NASCOBAL · NEXLETOL · NEXLIZET · NUCALA · NURTEC ODT · OFEV · OSMOLEX ER · Otezla · Ozempic · PENNSAID · PREMARIN · ProAir Digihaler · Prolia · QBREXZA · QSYMIA · RELISTOR ORAL · Repatha · SMARTVEST · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Talicia · The Vest System Model 105 Home Care · Tresiba · Trintellix · Tymlos · UBRELVY · UTIBRON · Utibron · VIBERZI · VRAYLAR · VYVANSE · Vascepa · XARELTO · XIFAXAN · Xenleta · Xofluza · ZolpiMist
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Mc Murray?
Compare pulmonary diseases in the Mc Murray area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
82
Per 100K population
39.1
County median income
$77,487
Nearest hospital
CANONSBURG GENERAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Celko is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 12% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Celko experienced with pulmonary gas exchange test?
Based on Medicare claims data, Dr. Celko performed 12 pulmonary gas exchange test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Celko receive payments from pharmaceutical companies?
Yes. Dr. Celko received a total of $14,351 from 60 companies across 701 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Celko's costs compare to other pulmonary diseases in Mc Murray?
Dr. Celko's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Celko) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →